Bank of New York Mellon’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.2M | Buy |
328,000
+13,798
| +4% | +$176K | ﹤0.01% | 2416 |
|
|
2025
Q4 | $2.82M | Buy |
314,202
+1,152
| +0.4% | +$15.9K | ﹤0.01% | 2644 |
|
|
2025
Q3 | $5.41M | Buy |
313,050
+1,882
| +0.6% | +$23.2K | ﹤0.01% | 2268 |
|
|
2025
Q2 | $2.92M | Buy |
311,168
+29,225
| +10% | +$240K | ﹤0.01% | 2561 |
|
|
2025
Q1 | $2M | Sell |
281,943
-2,671
| -0.9% | -$27K | ﹤0.01% | 2685 |
|
|
2024
Q4 | $3.32M | Sell |
284,614
-3,730
| -1% | -$58.2K | ﹤0.01% | 2505 |
|
|
2024
Q3 | $5.93M | Sell |
288,344
-75,962
| -21% | -$1.75M | ﹤0.01% | 2212 |
|
|
2024
Q2 | $8.15M | Buy |
364,306
+2,301
| +0.6% | +$54.8K | ﹤0.01% | 2071 |
|
|
2024
Q1 | $9.96M | Sell |
362,005
-31,590
| -8% | -$877K | ﹤0.01% | 1956 |
|
|
2023
Q4 | $12M | Sell |
393,595
-6,058
| -2% | -$174K | ﹤0.01% | 1885 |
|
|
2023
Q3 | $12.6M | Buy |
399,653
+607
| +0.2% | +$23.5K | ﹤0.01% | 1805 |
|
|
2023
Q2 | $16.3M | Buy |
399,046
+31,108
| +8% | +$1.26M | ﹤0.01% | 1666 |
|
|
2023
Q1 | $13.7M | Sell |
367,938
-10,812
| -3% | -$424K | ﹤0.01% | 1753 |
|
|
2022
Q4 | $13.2M | Buy |
378,750
+36,803
| +11% | +$1.75M | ﹤0.01% | 1776 |
|
|
2022
Q3 | $19.1M | Buy |
341,947
+42,208
| +14% | +$2.62M | ﹤0.01% | 1521 |
|
|
2022
Q2 | $15.5M | Buy |
299,739
+5,168
| +2% | +$262K | ﹤0.01% | 1685 |
|
|
2022
Q1 | $21.4M | Sell |
294,571
-1,148
| -0.4% | -$97.3K | ﹤0.01% | 1634 |
|
|
2021
Q4 | $35M | Sell |
295,719
-3,226
| -1% | -$404K | 0.01% | 1382 |
|
|
2021
Q3 | $40.1M | Buy |
298,945
+35,830
| +14% | +$5.42M | 0.01% | 1283 |
|
|
2021
Q2 | $42.6M | Buy |
263,115
+60,187
| +30% | +$4.69M | 0.01% | 1249 |
|
|
2021
Q1 | $16.3M | Sell |
202,928
-1,748
| -0.9% | -$117K | ﹤0.01% | 1816 |
|
|
2020
Q4 | $11.1M | Buy |
204,676
+16,707
| +9% | +$607K | ﹤0.01% | 1942 |
|
|
2020
Q3 | $3.74M | Buy |
187,969
+1,360
| +0.7% | +$28.4K | ﹤0.01% | 2366 |
|
|
2020
Q2 | $3.92M | Buy |
186,609
+13,643
| +8% | +$232K | ﹤0.01% | 2333 |
|
|
2020
Q1 | $2.12M | Sell |
172,966
-51,001
| -23% | -$687K | ﹤0.01% | 2516 |
|
|
2019
Q4 | $3.29M | Buy |
223,967
+9,365
| +4% | +$130K | ﹤0.01% | 2553 |
|
|
2019
Q3 | $2.87M | Buy |
214,602
+66,470
| +45% | +$1.06M | ﹤0.01% | 2553 |
|
|
2019
Q2 | $2.42M | Buy |
148,132
+22,386
| +18% | +$352K | ﹤0.01% | 2702 |
|
|
2019
Q1 | $2.15M | Buy |
125,746
+2,895
| +2% | +$43.2K | ﹤0.01% | 2742 |
|
|
2018
Q4 | $1.68M | Sell |
122,851
-8,200
| -6% | -$152K | ﹤0.01% | 2821 |
|
|
2018
Q3 | $3.75M | Buy |
131,051
+7,557
| +6% | +$220K | ﹤0.01% | 2534 |
|
|
2018
Q2 | $3.38M | Buy |
123,494
+44,015
| +55% | +$1.07M | ﹤0.01% | 2573 |
|
|
2018
Q1 | $1.68M | Buy |
79,479
+6,155
| +8% | +$151K | ﹤0.01% | 2909 |
|
|
2017
Q4 | $1.41M | Sell |
73,324
-415
| -0.6% | -$9.58K | ﹤0.01% | 3043 |
|
|
2017
Q3 | $1.83M | Buy |
73,739
+18,937
| +35% | +$357K | ﹤0.01% | 2889 |
|
|
2017
Q2 | $876K | Buy |
54,802
+23,126
| +73% | +$323K | ﹤0.01% | 3320 |
|
|
2017
Q1 | $446K | Buy |
31,676
+1,682
| +6% | +$22.6K | ﹤0.01% | 3594 |
|
|
2016
Q4 | $394K | Buy |
29,994
+9,403
| +46% | +$141K | ﹤0.01% | 3684 |
|
|
2016
Q3 | $351K | Sell |
20,591
-1,035
| -5% | -$20K | ﹤0.01% | 3708 |
|
|
2016
Q2 | $462K | Buy |
+21,626
| New | +$575K | ﹤0.01% | 3578 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
